Skip to content
Search resources Open menu

Alcohol Blackout

PTSD and Substance Use Disorders

Published

Snap Shot

  • The question: How often do posttraumatic stress disorder (PTSD) and alcohol, cannabis, opioid, and other substance use disorders occur together, why, and what does the overlap mean when a complainant, an accused, or a witness has one or both conditions?
  • What the research shows: PTSD and substance use disorders co-occur far more often than chance would predict in national, clinical, and military samples. The leading explanations are drinking or using to cope with symptoms, a higher risk of further trauma when substance use is heavy, and shared vulnerability, and the evidence supports more than one of them. In a review of lifetime prevalence, women were about twice as likely as men to have PTSD (roughly 10% to 12% versus 5% to 6%). Trauma-focused therapy can be delivered alongside substance use treatment and does not have to wait for abstinence.
  • What it does not show: The research does not show that a person with PTSD, a substance use disorder, or both is less truthful, that either condition caused a particular act, or that a particular person’s drinking was self-medication. Most studies are cross-sectional, and the evidence on causal direction is mixed.
  • The law: Expert testimony is governed by Rule 702 (as amended in 2023), Daubert, Kumho, Mil. R. Evid. 702 and Houser, and Ariz. R. Evid. 702; experts may not opine on a particular witness’s credibility. Mental-health records are privileged under Mil. R. Evid. 513 and Arizona law, subject to defined procedures. In Arizona, voluntary intoxication cannot negate a required mental state (A.R.S. § 13-503); in courts-martial it is not a defense but may be considered on actual knowledge, specific intent, willfulness, or premeditation (R.C.M. 916(l)(2)); both conditions may be weighed at sentencing. Counsel should confirm current authority.
  • Issues for each side: Prosecutors can explain that post-assault PTSD and heavier drinking are common and are not signs of fabrication; defense counsel can legitimately ask how intoxication and trauma symptoms affected what a witness perceived and remembers. Both sides should keep diagnoses from substituting for evidence about what happened.

PTSD is a disorder that can follow exposure to actual or threatened death, serious injury, or sexual violence. Its symptoms include intrusive memories and nightmares, avoidance of reminders, negative changes in mood and thinking, and heightened arousal and reactivity, lasting more than a month and causing significant distress or impairment (American Psychiatric Association [APA], 2022). Substance use disorders are patterns of alcohol or drug use that lead to impaired control, social problems, risky use, and physiological effects such as tolerance and withdrawal (APA, 2022). The two diagnoses appear together often enough that clinicians commonly screen for each when the other is present.

The combination reaches court from several directions. A complainant may have been drinking at the time of the alleged offense and may drink more heavily afterward, and treatment records may be sought or offered. An accused, often a service member or veteran, may have combat-related PTSD and an alcohol or drug problem that bear on mental state or sentencing. This paper reviews how often the conditions co-occur, the explanations for the overlap, findings in military and veteran samples, sex and gender differences, treatment, and the ways the research does and does not bear on testimony.

How Often the Conditions Occur Together

In the National Comorbidity Survey, a representative sample of 5,877 Americans aged 15 to 54, the estimated lifetime prevalence of PTSD was 7.8%; it was higher among women, the traumas most often associated with it were combat and witnessing violence among men and rape and sexual molestation among women, and PTSD was strongly comorbid with other disorders (Kessler et al., 1995). In the 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III), face-to-face interviews with 36,309 adults using DSM-5 criteria found past-year and lifetime PTSD prevalences of 4.7% and 6.1%, and PTSD was significantly associated with a broad range of substance use, mood, anxiety, and personality disorders; among those with lifetime PTSD, 59.4% had sought treatment, on average 4.5 years after onset (Goldstein et al., 2016).

Alcohol is the most studied pairing. A systematic review of 42 studies published from 2007 to 2012 found that the proportion of people with PTSD who also misused alcohol ranged from about 10% to 61% across populations, and the proportion of people with alcohol misuse who had PTSD ranged from 2% to 63%, with most estimates above 10%. Nearly all of the odds ratios linking the conditions were statistically significant, and alcohol misuse was most consistently associated with the avoidance and numbing and the hyperarousal symptoms of PTSD (Debell et al., 2014). The wide ranges reflect differences in samples (community, clinical, military) and in how each condition was measured.

The overlap extends to other substances. In more than 34,000 NESARC participants, lifetime trauma exposure was associated with lifetime cannabis use, and among trauma-exposed participants a PTSD diagnosis was associated with cannabis use disorder; the associations were modest (odds ratios near 1.2), and the authors called for longitudinal research on which came first (Kevorkian et al., 2015). Among 141,029 Iraq and Afghanistan veterans with a pain diagnosis, 17.8% of those with PTSD were prescribed opioids within a year, compared with 6.5% of those without a mental-health diagnosis; veterans with PTSD were also more likely to receive higher doses, more than one opioid, sedative-hypnotics at the same time, and early refills, and opioid prescription was associated with more adverse outcomes such as accidents and overdose, most markedly in veterans with PTSD (Seal et al., 2012). That study concerns prescribed opioids and documented risk markers, not diagnosed opioid use disorder.

Why the Conditions Travel Together

Three explanations dominate the literature, and they are not mutually exclusive. The self-medication account holds that people use alcohol or drugs to relieve distressing symptoms (Khantzian, 1997). A systematic review of 24 studies testing that account for PTSD and problem drinking found that the studies generally supported it but were limited in rigor, in part because “drinking to cope” with trauma symptoms was measured inconsistently or not at all (Hawn et al., 2020). Daily-diary research adds detail. In a study of 136 women with past sexual victimization and 40 women with no trauma history, women were somewhat more likely to drink on days when their intrusive and avoidance symptoms were higher, while on days with more dysphoric symptoms or negative mood they drank slightly less, and women with lower confidence in their coping drank more as distress rose (Kaysen et al., 2014). In a sample of 1,863 women who had experienced adult sexual assault, PTSD symptoms were linked to using substances to cope, which in turn fully accounted for the association between PTSD and problem drug use and partly accounted for the association with problem drinking (Ullman et al., 2013).

The second account runs the other way: heavy substance use can increase exposure to dangerous situations and thus to trauma. In a national probability sample of 3,006 women followed for two years, drug use at the first interview increased the odds of a new assault during follow-up, although alcohol abuse did not; after a new assault, the odds of both alcohol abuse and drug use rose, even among women with no previous use or assault history (Kilpatrick et al., 1997). The authors described a cycle for drug use in which each problem raises the risk of the other. The third account emphasizes shared vulnerability, such as earlier adversity or other risk factors that raise the odds of both conditions. The research supports some role for each account, and no study can say which applied to a particular person.

Military and Veteran Samples

Military samples matter because so many contested cases involve service members. In the Millennium Cohort Study, which surveyed 48,481 service members before and after the early years of the wars in Iraq and Afghanistan, Reserve and National Guard personnel who deployed and reported combat exposure were significantly more likely than those who did not deploy to report new-onset heavy weekly drinking, binge drinking, and alcohol-related problems, and the youngest members were at highest risk (Jacobson et al., 2008). Among 3,119 veterans in NESARC-III, lifetime PTSD prevalence was 6.9%, and after adjustment for demographics PTSD was associated with nicotine, drug, and alcohol use disorders (adjusted odds ratios about 3.4, 3.1, and 2.1) as well as with mood, anxiety, and personality disorders (Smith et al., 2016).

Cannabis has drawn particular attention because some veterans report using it to manage PTSD symptoms. In a randomized, double-blind crossover trial with 80 veterans, three weeks of smoked cannabis at three different concentrations did not reduce PTSD symptom severity more than placebo by the end of the first stage (Bonn-Miller et al., 2021). The 2023 Department of Veterans Affairs and Department of Defense clinical practice guideline recommends against benzodiazepines and against cannabis or cannabis-derived products for PTSD (Schnurr et al., 2024). The paper Alcohol, Cannabis, and Blackouts discusses combined use and memory.

Sex and Gender Differences

Women were about twice as likely as men to have PTSD in one review, which reported lifetime prevalence of roughly 10% to 12% in women and 5% to 6% in men, and noted that women are more often exposed to high-impact trauma such as sexual violence, and at younger ages (Olff, 2017). The same pattern appeared among veterans, where lifetime PTSD prevalence was 13.2% among women (Smith et al., 2016). Several of the studies on drinking to cope and on the assault–substance use cycle sampled only women (Kaysen et al., 2014; Kilpatrick et al., 1997; Ullman et al., 2013), and several treatment and military studies were mostly male (Back et al., 2019; Seal et al., 2012), so sex differences in the pathways themselves are not well established. Men are also sexually assaulted, including in military settings, and the research on men’s post-assault substance use is thinner; the findings above should not be read as applying only to women or as excluding male complainants. All of these are group-level differences and cannot indicate how a particular person responded to trauma.

Treatment

Integrated treatment, addressing both conditions at the same time, has become the standard recommendation. A meta-analysis of 14 randomized trials found that individual trauma-focused cognitive-behavioral therapy delivered alongside substance use treatment reduced PTSD severity more than usual care, with reductions in substance use appearing at five to seven months; fewer participants completed trauma-focused treatment, and the authors rated the evidence as low quality (Roberts et al., 2015). In a trial with 81 veterans, most of them men, an integrated treatment incorporating prolonged exposure produced greater reductions in PTSD symptoms than relapse-prevention therapy, with similar reductions in substance use severity during treatment and fewer drinks per drinking day at six months (Back et al., 2019). An individual-patient-data meta-analysis pooling 36 trials and 4,046 participants found that trauma-focused therapy combined with medication for substance use disorders produced the largest effects relative to usual care on PTSD severity and alcohol use severity at the end of treatment (Hien et al., 2023). A 2026 randomized trial with 209 patients found no long-term difference between starting PTSD treatment at once or after substance use treatment, with an early advantage for starting at once, and concluded that PTSD treatment need not be delayed (Lortye et al., 2026).

Trauma-focused treatment is designed to reduce the distress attached to memories; the treatment studies summarized here do not show that it changes what a person reports having happened. The timing of treatment relative to an interview is a fact for the record, for any witness, and not by itself a basis for inferring a change in an account; the Memory in the Courtroom paper on EMDR and memory addresses that question.

What the Research Means for Witnesses and Accused Persons

For a complainant, PTSD symptoms and increased drinking after an assault are common outcomes, consistent with the research above, and are not evidence that the report is false. Conversely, a diagnosis of PTSD does not corroborate a particular account, because PTSD follows many kinds of trauma and its presence cannot identify which event caused it or how it occurred. When intoxication at the time of an event is combined with later PTSD, memory questions become more complex. Alcohol at high doses can prevent the formation of lasting memories (White, 2003), whereas the PTSD symptom of being unable to recall an important part of a traumatic event is described as typically reflecting dissociative amnesia, not head injury, alcohol, or drugs (APA, 2022). A gap in memory after a heavily intoxicated evening is therefore not, by itself, a PTSD symptom, and it is not, by itself, evidence that nothing happened; the paper Introduction to Alcohol Blackouts: A Primer explains blackouts, and the Memory in the Courtroom paper “False Memory in Trauma and PTSD” reviews research on memory accuracy in PTSD.

For an accused, the research shows that the conditions often co-occur and that combat exposure is linked to new drinking problems, but it does not show that either condition caused a particular act or removed a particular person’s capacity to form intent, and, on the intoxication question, the Military Judges’ Benchbook treats intoxication from drinking compelled by alcoholism as voluntary as a matter of law (verify the instruction number), an accused who claims involuntary intoxication bears the burden of proving it (United States v. MacDonald, 73 M.J. 426 (C.A.A.F. 2014)), and Arizona’s statute speaks of voluntary use (A.R.S. § 13-503), so counsel should check current Arizona authority on how a substance use disorder is treated (see Voluntary Intoxication, Blackout, and Criminal Responsibility).

Hypothetical Example. Consider a hypothetical veteran charged with assault after an evening of heavy drinking, who has a documented history of combat-related PTSD and an alcohol use disorder and reports little memory of the incident. An expert could explain that the two conditions frequently co-occur, that combat exposure is associated with new-onset drinking problems, and that drinking to cope has been documented at the group level. The research does not establish that this veteran drank to self-medicate that night, that PTSD caused the assault, or that the reported memory gap reflects a blackout rather than reconstruction or other causes. In Arizona, voluntary intoxication cannot negate a required mental state (A.R.S. § 13-503), so the history would bear chiefly on mitigation; in courts-martial, evidence of intoxication may be considered on specific intent, actual knowledge, willfulness, or premeditation (R.C.M. 916(l)(2)), and the history otherwise bears chiefly on extenuation and mitigation.

Limits of the Evidence

Most of the prevalence research is cross-sectional and cannot establish which condition came first, and the longitudinal studies cited here sampled women and relied on self-report. Estimates vary widely with the sample, the definitions used, and the diagnostic edition. Daily-diary studies capture same-day associations, not causation. Many treatment trials involved mostly male veterans or specialized centers. Research on opioids and cannabis is newer and thinner than research on alcohol. Most fundamentally, group research cannot establish whether a particular person has PTSD, why a particular person drank, whether a diagnosis explains a particular act, or whether a particular account is accurate.

Questions to Ask About This Research

When a co-occurrence figure is offered, counsel can ask who was studied and how each condition was measured, since the published range for alcohol misuse among people with PTSD spans roughly 10% to 61% (Debell et al., 2014). When the self-medication account is offered to explain a person’s drinking, counsel can ask how strong the evidence is, given a systematic review that found support but limited rigor (Hawn et al., 2020), and whether anything in the record shows the person’s own reasons for drinking. When Kilpatrick et al. (1997) is cited to suggest that substance use raises the risk of assault, counsel can ask what exactly was found: drug use, but not alcohol abuse, predicted new assaults, and assault predicted later substance use. When a diagnosis is offered as corroboration of an account, or as a reason to doubt one, counsel can ask whether the research supports that inference at all. These questions are explained in “Reading Research Claims: A Guide for Attorneys” on this site.

PTSD, Substance Use, and the Law

Federal and Military Standards

Expert testimony on PTSD and substance use is governed by Federal Rule of Evidence 702, as amended December 1, 2023, which requires the proponent to show that it is more likely than not that the testimony rests on sufficient facts or data, reflects reliable principles and methods, and reflects a reliable application of those methods to the case; Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993) and Kumho Tire Co. v. Carmichael (1999) extend that gatekeeping to all expert testimony, including clinical opinion. In courts-martial, Military Rule of Evidence 702 tracks the federal rule; the 2023 federal amendment took effect in the military rule in 2025 (Joint Service Committee on Military Justice, 2025), and practitioners should confirm current text. Military judges also apply United States v. Houser (1993), and no witness may offer an opinion that a person is or is not telling the truth (United States v. Brooks, 2007). Communications with a psychotherapist are privileged under Military Rule of Evidence 513, subject to its exceptions and procedures, and diagnoses and treatments in medical records are not uniformly privileged (United States v. Mellette, 2022); the Counterintuitive Testimony paper on mental-health records of adult complainants covers access in detail.

Voluntary intoxication is not a defense in courts-martial, but evidence of it may be considered on actual knowledge, specific intent, willfulness, or premeditation (R.C.M. 916(l)(2)), and the Military Judges’ Benchbook instructs that, as a matter of law, intoxication from drinking compelled by alcoholism is treated as voluntary (Department of the Army, 2025, Instruction 5-21, Note 3; verify instruction number); an accused who claims involuntary intoxication bears the burden of proving it by clear and convincing evidence (United States v. MacDonald, 73 M.J. 426 (C.A.A.F. 2014)). Lack of mental responsibility requires a severe mental disease or defect (R.C.M. 916(k)(1)), and questions of capacity or responsibility may be referred for examination under R.C.M. 706. Evidence of PTSD and substance use may be offered in extenuation and mitigation (R.C.M. 1001). At federal sentencing, courts consider the factors in 18 U.S.C. § 3553(a); the 2025 Guidelines amendment (Amendment 836) removed most departure provisions, including departures based on specific personal characteristics, and compiled the deleted departure provisions in Appendix B; the Commission described the change as outcome neutral and as not limiting the information courts may consider (U.S. Sentencing Commission, 2025a, 2025b).

Arizona

Arizona Rule of Evidence 702 adopted the Daubert standard in 2012 and was amended effective January 1, 2024, to track the 2023 federal amendment (Ariz. Sup. Ct. Order R-23-0004). General educational testimony is permitted if it satisfies Rules 702 and 403 (State v. Salazar-Mercado, 2014), but an expert may not opine on a particular witness’s credibility (State v. Lindsey, 1986, 149 Ariz. at 475; State v. Moran, 1986). When a defendant seeks a victim’s privileged mental-health records, in camera review requires a sufficiently specific showing of a reasonable possibility that the records contain information to which the defendant is constitutionally entitled (R.S. v. Thompson, 2021, ¶ 30). Temporary intoxication from voluntary use of alcohol or drugs is not a defense to any criminal act or requisite state of mind (A.R.S. § 13-503); expert evidence of a mental condition short of insanity may not be used to negate mens rea (State v. Mott, 1997; Clark v. Arizona, 2006); and for a guilty-except-insane verdict, a mental disease or defect does not include disorders resulting from acute voluntary intoxication or withdrawal (A.R.S. § 13-502). At sentencing, the court considers as mitigation, among other circumstances, whether the defendant’s capacity to appreciate the wrongfulness of the conduct or to conform it to the law was significantly impaired but not so impaired as to constitute a defense, and any other factor relevant to character or background (A.R.S. § 13-701(E)).

Special Issues in Legal Practice

The principles described above apply with equal force to every party in a legal proceeding. The science operates the same way regardless of who is asking the questions, and the research summarized here does not by itself favor either side. What differs between the parties is not the science but the vantage point — the particular places where these issues tend to surface, and the particular errors each party is best positioned to guard against. The two summaries below identify those recurring issues. They are offered for orientation, not as litigation strategy; in every case the controlling question is what the evidence in that case will, and will not, support, and the expert’s role is to inform the trier of fact rather than to advocate for either side.

Special Issues for Prosecutors

The research supports several points prosecutors can legitimately present. PTSD and increased alcohol or drug use are common after sexual and other assaults, and their appearance after a reported assault is consistent with the research rather than a sign of an unreliable report. Prior substance use does not make a person responsible for being assaulted, and the longitudinal research shows that assault itself raises the risk of later substance problems. When an accused offers PTSD or a substance use disorder, prosecutors can point out that the research describes group associations and that, in Arizona, voluntary intoxication cannot negate a required mental state, while in courts-martial it is not a defense but may be considered on specified mental elements.

The research also counsels caution. A PTSD diagnosis does not corroborate a particular account, because it cannot identify which event caused it, and testimony offered for that purpose runs into the rules against vouching. A party’s intoxication at the time of the event, whether a complainant’s or an accused’s, is a subject the factfinder may weigh, and the memory effects of heavy drinking apply to everyone. Documented illness is a recognized subject at sentencing, and the research does not support treating a diagnosis as fabricated or as an explanation for a particular act.

Special Issues for Defense

The research supports several propositions defense counsel can legitimately present. Heavy intoxication at the time of an event can impair what a witness encoded and later remembers, and PTSD-related symptoms and treatment can affect how memories are experienced; questions about what a witness drank, when treatment occurred, and how an account developed are grounded in the literature. For an accused, the frequent co-occurrence of combat exposure, PTSD, and drinking problems, and the effectiveness of integrated treatment, are legitimate subjects in mitigation, and requests for records can be tied to specific conditions and time periods.

The research also counsels caution about the limits that apply to the defense. A complainant’s PTSD, substance use, or treatment history is not evidence of fabrication, and arguing otherwise is not supported by the research. Group findings on self-medication cannot show why a particular accused drank or that a disorder caused the charged conduct, and the intoxication rules summarized above limit its use on the required mental state. Documented illness is a recognized subject at sentencing, and the research does not support treating a diagnosis as fabricated or as an explanation for a particular act. The same memory limitations that apply to an intoxicated complainant apply to an intoxicated accused and to defense witnesses.

This paper is for educational purposes only and is not legal advice. The author is a psychologist, not an attorney; summaries of law are general and must be verified against current authority or with a licensed attorney.

References

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787

Back, S. E., Killeen, T., Badour, C. L., Flanagan, J. C., Allan, N. P., Ana, E. S., Lozano, B., Korte, K. J., Foa, E. B., & Brady, K. T. (2019). Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans. Addictive Behaviors, 90, 369–377. https://doi.org/10.1016/j.addbeh.2018.11.032

Bonn-Miller, M. O., Sisley, S., Riggs, P., Yazar-Klosinski, B., Wang, J. B., Loflin, M. J. E., Shechet, B., Hennigan, C., Matthews, R., Emerson, A., & Doblin, R. (2021). The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. PLOS ONE, 16(3), Article e0246990. https://doi.org/10.1371/journal.pone.0246990

Debell, F., Fear, N. T., Head, M., Batt-Rawden, S., Greenberg, N., Wessely, S., & Goodwin, L. (2014). A systematic review of the comorbidity between PTSD and alcohol misuse. Social Psychiatry and Psychiatric Epidemiology, 49(9), 1401–1425. https://doi.org/10.1007/s00127-014-0855-7

Department of the Army. (2025). Military judges’ benchbook (DA Pamphlet 27-9, 29 July 2025).

Goldstein, R. B., Smith, S. M., Chou, S. P., Saha, T. D., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Huang, B., & Grant, B. F. (2016). The epidemiology of DSM-5 posttraumatic stress disorder in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Social Psychiatry and Psychiatric Epidemiology, 51(8), 1137–1148. https://doi.org/10.1007/s00127-016-1208-5

Hawn, S. E., Cusack, S. E., & Amstadter, A. B. (2020). A systematic review of the self-medication hypothesis in the context of posttraumatic stress disorder and comorbid problematic alcohol use. Journal of Traumatic Stress, 33(5), 699–708. https://doi.org/10.1002/jts.22521

Hien, D. A., Morgan-López, A. A., Saavedra, L. M., Ruglass, L. M., Ye, A., López-Castro, T., Fitzpatrick, S., Killeen, T. K., Norman, S. B., Ebrahimi, C. T., & Back, S. E. (2023). Project Harmony: A meta-analysis with individual patient data on behavioral and pharmacologic trials for comorbid posttraumatic stress and alcohol or other drug use disorders. American Journal of Psychiatry, 180(2), 155–166. https://doi.org/10.1176/appi.ajp.22010071

Jacobson, I. G., Ryan, M. A. K., Hooper, T. I., Smith, T. C., Amoroso, P. J., Boyko, E. J., Gackstetter, G. D., Wells, T. S., & Bell, N. S. (2008). Alcohol use and alcohol-related problems before and after military combat deployment. JAMA, 300(6), 663–675. https://doi.org/10.1001/jama.300.6.663

Joint Service Committee on Military Justice. (2025). Amendments to the Military Rules of Evidence since 1984 (G. E. Maggs, Ed.; 2025 ed.). https://jsc.defense.gov/Portals/99/MRE%20Amendments%202025.pdf

Kaysen, D., Stappenbeck, C. A., Rhew, I., & Simpson, T. L. (2014). Proximal relationships between PTSD and drinking behavior. European Journal of Psychotraumatology, 5(1), Article 26518. https://doi.org/10.3402/ejpt.v5.26518

Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M., & Nelson, C. B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52(12), 1048–1060. https://doi.org/10.1001/archpsyc.1995.03950240066012

Kevorkian, S., Bonn-Miller, M. O., Belendiuk, K., Carney, D. M., Roberson-Nay, R., & Berenz, E. C. (2015). Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample. Psychology of Addictive Behaviors, 29(3), 633–638. https://doi.org/10.1037/adb0000110

Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. https://doi.org/10.3109/10673229709030550

Kilpatrick, D. G., Acierno, R., Resnick, H. S., Saunders, B. E., & Best, C. L. (1997). A 2-year longitudinal analysis of the relationships between violent assault and substance use in women. Journal of Consulting and Clinical Psychology, 65(5), 834–847. https://doi.org/10.1037/0022-006X.65.5.834

Lortye, S., Faber, N. N. M., Will, J. P., Marquenie, L. A., Lommerse, N. M., Goudriaan, A. E., Arntz, A., & de Waal, M. M. (2026). Timing and type of posttraumatic stress disorder treatment in patients with co-occurring substance use disorder and posttraumatic stress disorder – A randomized controlled trial. Journal of Substance Use and Addiction Treatment, 183, Article 209878. https://doi.org/10.1016/j.josat.2025.209878

Olff, M. (2017). Sex and gender differences in post-traumatic stress disorder: An update. European Journal of Psychotraumatology, 8(Suppl. 4), Article 1351204. https://doi.org/10.1080/20008198.2017.1351204

Roberts, N. P., Roberts, P. A., Jones, N., & Bisson, J. I. (2015). Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: A systematic review and meta-analysis. Clinical Psychology Review, 38, 25–38. https://doi.org/10.1016/j.cpr.2015.02.007

Schnurr, P. P., Hamblen, J. L., Wolf, J., Coller, R., Collie, C., Fuller, M. A., Holtzheimer, P. E., Kelly, U., Lang, A. J., McGraw, K., Morganstein, J. C., Norman, S. B., Papke, K., Petrakis, I., Riggs, D., Sall, J. A., Shiner, B., Wiechers, I., & Kelber, M. S. (2024). The management of posttraumatic stress disorder and acute stress disorder: Synopsis of the 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline. Annals of Internal Medicine, 177(3), 363–374. https://doi.org/10.7326/M23-2757

Seal, K. H., Shi, Y., Cohen, G., Cohen, B. E., Maguen, S., Krebs, E. E., & Neylan, T. C. (2012). Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA, 307(9), 940–947. https://doi.org/10.1001/jama.2012.234

Smith, S. M., Goldstein, R. B., & Grant, B. F. (2016). The association between post-traumatic stress disorder and lifetime DSM-5 psychiatric disorders among veterans: Data from the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). Journal of Psychiatric Research, 82, 16–22. https://doi.org/10.1016/j.jpsychires.2016.06.022

Ullman, S. E., Relyea, M., Peter-Hagene, L., & Vasquez, A. L. (2013). Trauma histories, substance use coping, PTSD, and problem substance use among sexual assault victims. Addictive Behaviors, 38(6), 2219–2223. https://doi.org/10.1016/j.addbeh.2013.01.027

U.S. Sentencing Commission. (2025a). Amendments in brief: Simplification [Amendment effective November 1, 2025]. https://www.ussc.gov/sites/default/files/pdf/amendment-process/amendments-in-brief/AIB_2025-simplification.pdf

U.S. Sentencing Commission. (2025b). Guidelines manual (Chapter One). https://www.ussc.gov/sites/default/files/pdf/guidelines-manual/2025/CHAPTER_1.pdf

White, A. M. (2003). What happened? Alcohol, memory blackouts, and the brain. Alcohol Research & Health, 27(2), 186–196.

Legal Authorities

Clark v. Arizona, 548 U.S. 735 (2006).

Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993).

Kumho Tire Co. v. Carmichael, 526 U.S. 137 (1999).

R.S. v. Thompson, 251 Ariz. 111, 485 P.3d 1068 (2021).

State v. Lindsey, 149 Ariz. 472, 720 P.2d 73 (1986).

State v. Moran, 151 Ariz. 378, 728 P.2d 248 (1986).

State v. Mott, 187 Ariz. 536, 931 P.2d 1046 (1997).

State v. Salazar-Mercado, 234 Ariz. 590, 325 P.3d 996 (2014).

United States v. Brooks, 64 M.J. 325 (C.A.A.F. 2007).

United States v. Houser, 36 M.J. 392 (C.M.A. 1993).

United States v. MacDonald, 73 M.J. 426 (C.A.A.F. 2014).

United States v. Mellette, 82 M.J. 374 (C.A.A.F. 2022).

18 U.S.C. § 3553(a).

Ariz. Rev. Stat. Ann. §§ 13-502, 13-503, 13-701(E).

Fed. R. Evid. 702.

Ariz. R. Evid. 403, 702.

Ariz. Sup. Ct. Order R-23-0004 (amending Ariz. R. Evid. 702, effective Jan. 1, 2024).

Mil. R. Evid. 513, 702, 1102.

Rule for Courts-Martial 706, 916(k), 916(l), 1001.

Related topic papers: Anxiety Disorders and Alcohol · Bipolar Disorder and Substance Use · Alcohol, Cannabis, and Blackouts · Voluntary Intoxication, Blackout, and Criminal Responsibility · Introduction to Alcohol Blackouts: A Primer

Related topics from Arizona Forensic Services: Memory in the Courtroom: False Memory in Trauma and PTSD · Counterintuitive Testimony: Mental-Health Records of Adult Complainants · Courts-Martial